Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

April 2, 2024

https://www.globenewswire.com/news-release/2024/04/02/2856463/0/en/Pulmonx-Announces-Appointment-of-Mehul-Joshi-as-Chief-Financial-Officer.html

REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq:LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today announced the appointment of Mehul Joshi as Chief Financial Officer, effective April 3, 2024. He succeeds John McKune, who has served as the Company’s Interim Chief Financial Officer since October 10, 2023, and will transition to his prior role as Vice President, Corporate Controller.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.